Highlights
- Wesfarmers (ASX:WES) delivered FY2026 Earnings growth supported by Bunnings, Kmart and healthcare operations.
- The company increased its fully Franked Dividend following stronger annual profit.
- Free Cash Flow reached approximately A$4 billion during FY2026.
- Investors are monitoring consumer demand, Capital Expenditure and future returns from strategic investments.
Wesfarmers (ASX:WES) closed FY2026 with growth across most of its major businesses, supported by resilient retail performance and improved earnings from several divisions.
The company’s latest results highlighted continued strength in Bunnings and Kmart Group, while investments in areas such as Officeworks transformation and lithium development remain important parts of the longer-term strategy.
Latest Development
Wesfarmers (ASX:WES) reported its FY2026 result on 27 August 2026 for the year ended 30 June 2026.
Group Revenue increased 3.4% to A$47.274 billion, while net profit after tax rose 8.3% to A$2.874 billion, excluding prior-period significant items.
Earnings before interest and tax on the same basis reached A$4.493 billion, increasing 7.3%.
The board declared a fully franked final dividend of A$1.20 per share, taking FY2026 distributions to A$2.22 per share, representing a 7.8% increase.
Company Overview
Wesfarmers (ASX:WES) is a diversified Australian conglomerate with operations spanning retail, healthcare, industrial businesses and resources.
Its largest Business is Bunnings, the home improvement and outdoor living retailer.
The group also owns Kmart Group, including Kmart and Target, Officeworks, Wesfarmers Health, Wesfarmers Chemicals, Energy & Fertilisers, and industrial and safety businesses.
The company also has exposure to lithium through the Mount Holland project.
Wesfarmers has been listed on the ASX since 1984 and originated as a Western Australian farmers’ cooperative.
Financial and Operational Position
Bunnings delivered earnings of A$2.455 billion, increasing 5.1%, on revenue of A$20.399 billion, up 4.1%.
Kmart Group generated earnings of A$1.109 billion, up 6.0%, on revenue of A$11.751 billion, which increased 2.8%.
Wesfarmers Chemicals, Energy and Fertilisers increased earnings 18.5% to A$473 million.
Wesfarmers Health earnings rose 12.2% to A$92 million, while the industrial and safety division increased earnings 16.9% to A$76 million.
Officeworks earnings declined 22.2% to A$165 million due to approximately A$40 million of one-off costs associated with its transformation programme.
Free cash flow reached approximately A$4 billion, increasing 15.8%.
Gross capital expenditure was A$1.2 billion, while net capital expenditure was A$779 million, down 29%.
Net financial Debt was A$5.3 billion, with finance costs of A$202 million and Leverage of 1.9 times EBITDA.
Recent Developments
Wesfarmers (ASX:WES) provided an early indication of FY2027 trading conditions following the FY2026 result.
Bunnings sales growth was tracking slightly above the 3.9% growth recorded during the second half of FY2026.
Kmart Group was tracking broadly in line with its 2.2% second-half FY2026 growth rate.
Officeworks trading was slightly below its previous 2.7% growth pace.
The company continues to focus on improving operational performance while investing in future growth opportunities.
What Investors May Watch Next
Capital expenditure guidance for FY2027 is A$1.3 billion to A$1.5 billion, including approximately A$200 million directed towards the Mount Holland expansion.
Investors will monitor whether these investments generate attractive long-term returns while managing higher funding costs.
Management has indicated that borrowing costs may increase during FY2027 due to higher debt levels, increased capital expenditure and elevated funding rates.
The next scheduled major reporting milestone is the half-year FY2027 result expected in February 2027, with the Christmas trading period for Bunnings and Kmart also an important seasonal indicator.
Risks
Wesfarmers remains exposed to Australian consumer spending, housing activity and renovation demand.
Officeworks remains in the middle of a transformation programme, while lithium Economics remain dependent on spodumene pricing and market conditions.
Higher finance costs may affect future earnings growth.
Management has also highlighted uncertainty around inflation, interest rates and housing conditions influencing consumer confidence.
Conclusion
Wesfarmers (ASX:WES) enters September 2026 with a portfolio delivering steady earnings growth, a higher dividend and strong free cash flow generation.
The company’s key challenge is balancing resilient retail performance with higher capital commitments and funding costs.
For investors following Wesfarmers (ASX:WES), future performance will depend on whether Bunnings and Kmart maintain sales momentum, while strategic investments such as Officeworks transformation and Mount Holland deliver expected returns.


_11_12_2026_12_29_40_915327.jpg)



Please wait processing your request...